The Patent Finder

Terms ending in 2036

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,840,736Nucleic Acid Biomarker and Use Thereof
In force
 · High confidence
Daiichi Sankyo Europe GmbHIn forceHigh confidence
US 10,561,800Skin Sensors for Drug Delivery Devices
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,040,135Integrated Pierceable Seal Fluid Pathway Connection and Drug Containers for Drug Delivery Pumps
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,303,674Drug Injection Device with Visual and Audio Indicators
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 10,611,850Crystalline Antibody Formulations
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,773,184Crystalline Antibody Formulations
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,873,344Protein Biomarker and Uses Thereof
In force
 · High confidence
Daiichi Sankyo Europe GmbHIn forceHigh confidence
US 10,933,132Combination of Epigenetic Factors and Bispecific Compounds Targeting CD33 and CD3 in the Treatment of Myeloid Leukemia
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 11,672,905Rotationally Biased Insertion Mechanism for a Drug Delivery Pump
In force
 · Medium confidence
Amgen Inc.In forceMedium confidence
US 12,208,237Rotationally Biased Insertion Mechanism for a Drug Delivery Pump
In force
 · High confidence
Amgen Inc.In forceHigh confidence
58 more term ends in 2036 · Pro
10 of 68 patents shown. Soonest term end first, then patent number.
Pro members see all 68.
Upgrade to Pro
63 of these are in force and held by Amgen Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited